These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 14712939)

  • 21. A delay-differential equation model of HIV related cancer-immune system dynamics.
    Foryś U; Poleszczuk J
    Math Biosci Eng; 2011 Apr; 8(2):627-41. PubMed ID: 21631150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emergence of HIV-1 drug resistance during antiretroviral treatment.
    Rong L; Feng Z; Perelson AS
    Bull Math Biol; 2007 Aug; 69(6):2027-60. PubMed ID: 17450401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Latency: the hidden HIV-1 challenge.
    Marcello A
    Retrovirology; 2006 Jan; 3():7. PubMed ID: 16412247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modelling the influence of activation-induced apoptosis of CD4+ and CD8+ T-cells on the immune system response of a HIV-infected patient.
    Stan GB; Belmudes F; Fonteneau R; Zeggwagh F; Lefebvre MA; Michelet C; Ernst D
    IET Syst Biol; 2008 Mar; 2(2):94-102. PubMed ID: 18397120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Uses and abuses of mathematics in biology.
    May RM
    Science; 2004 Feb; 303(5659):790-3. PubMed ID: 14764866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy.
    Deeks SG; Walker BD
    Immunity; 2007 Sep; 27(3):406-16. PubMed ID: 17892849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV-1 dynamics in vivo: implications for therapy.
    Simon V; Ho DD
    Nat Rev Microbiol; 2003 Dec; 1(3):181-90. PubMed ID: 15035022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimal drug treatment regimens for HIV depend on adherence.
    Krakovska O; Wahl LM
    J Theor Biol; 2007 Jun; 246(3):499-509. PubMed ID: 17320115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Computational models of antiviral toxicity.
    Samuels DC
    Curr Opin Drug Discov Devel; 2007 Jan; 10(1):43-8. PubMed ID: 17265740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current status of HIV infection: a review for non-HIV-treating physicians.
    Knoll B; Lassmann B; Temesgen Z
    Int J Dermatol; 2007 Dec; 46(12):1219-28. PubMed ID: 18173512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toll-like receptor signaling in HIV-1 infection: a potential target for therapy?
    Meier A; Altfeld M
    Expert Rev Anti Infect Ther; 2007 Jun; 5(3):323-6. PubMed ID: 17547495
    [No Abstract]   [Full Text] [Related]  

  • 32. An enhanced agent based model of the immune system response.
    Baldazzi V; Castiglione F; Bernaschi M
    Cell Immunol; 2006 Dec; 244(2):77-9. PubMed ID: 17416357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimization of HAART with genetic algorithms and agent-based models of HIV infection.
    Castiglione F; Pappalardo F; Bernaschi M; Motta S
    Bioinformatics; 2007 Dec; 23(24):3350-5. PubMed ID: 17942443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distinct effects of protease and reverse transcriptase inhibition in an immunological model of HIV-1 infection with impulsive drug effects.
    Smith RJ; Wahl LM
    Bull Math Biol; 2004 Sep; 66(5):1259-83. PubMed ID: 15294425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New discoveries in HIV research.
    Proj Inf Perspect; 2001 Aug; (33):13-4. PubMed ID: 11838407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decrease of replicative capacity of HIV isolates after genotypic guided change of therapy.
    Sarmati L; Nicastri E; Montano M; Dori L; Buonomini AR; d'Ettorre G; Gatti F; Parisi SG; Vullo V; Andreoni M
    J Med Virol; 2004 Apr; 72(4):511-6. PubMed ID: 14981751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An intra-host mathematical model on interaction between HIV and malaria.
    Xiao D; Bossert WH
    Bull Math Biol; 2010 Oct; 72(7):1892-911. PubMed ID: 20177803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Eradication of HIV in infected patients: some potential approaches.
    Yang QE
    Med Sci Monit; 2004 Jul; 10(7):RA155-65. PubMed ID: 15232518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamic treatment model to examine the association between phenotypic drug resistance and duration of HIV viral suppression.
    Snedecor SJ
    Bull Math Biol; 2005 Nov; 67(6):1315-32. PubMed ID: 16005505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV hollow fiber SCID model for antiviral therapy comparison with SCID/hu model.
    Taggart BR; Harrington P; Hollingshead M
    Antiviral Res; 2004 Jul; 63(1):1-6. PubMed ID: 15196814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.